Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mannitol for Childhood Cerebral Malaria
NCT00113854Phase 3Unknown
- Sponsor
- Makerere University
- Start
- Oct 2004
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cerebral malaria (CM) comparing Mannitol with Placebo (2 arms). Primary endpoint: Coma recovery time. Status: unknown.
02
Drugs
Bronchitol
03
Conditions
cerebral malaria (CM)
Beyond the preview
Go deeper on NCT00113854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00113854.